On the last day of AGBT, attendees crowded the room for the session everyone had been waiting for: New Genomic Frontiers, highlighting sequencing advances from Pacific Biosciences, Complete Genomics, Life Technologies, Ion Torrent, and Helicos. At Genetic Interference, Luke Jostins gives a quick run-down of each and he notes that "we are starting to see a divergence in sequencing technologies … This means that the scientists themselves can more closely tailor their choice of tech to fit their situation."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Next-gen Challenges

Human Knockouts

Peek Inside

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.